Justin Virgin – Executive Director – Terrain Minerals (ASX:TMX) is a West Australian based minerals exploration company focused on the world class mineral provinces in Western Australia. Terrain is actively looking for opportunities within other states of Australia and internationally.
Copyright 2024 – Finance News Network
26 Aug 2021 - Chimeric Therapeutics Limited (ASX:CHM) Chief Operating Officer Jennifer Chow talks about the company's licensing of a novel, third-generation CDH17 CAR T cell therapy from the University of Pennsylvania, its recent FDA IND clearance and plans for ongoing growth.
29 Jul 2021 - BARD1 Life Sciences Limited (ASX:BD1) CEO Dr Leearne Hinch introduces the company, discussing its recent capital raising and share purchase plan.
22 Sep 2021 - Shaw and Partners Chief Investment Officer Martin Crabb discusses Evergrande, the Chinese economy, implications for the Australian equity market and monetary policy.
11 Aug 2020 - Regeneus (ASX:RGS) CEO, Leo Lee talks about its collaboration with Kyocera of Japan to market Progenza its cell therapy treatment for anti-inflammatory treatment and repair of damaged or diseased tissue.
06 May 2020 - Acorn Capital Investment Fund Ltd. (ASX: ACQ) Head of Research and Portfolio Manager for the Consumer Discretionary, Consumer Staples and Information Technology sectors, Robert Bruce talks about the listed investment company, the fund’s composition and outlook for the next 6 months and longer term.
21 Oct 2019 - PPK Group Limited (ASX:PPK) Executive Chairman, Robin Levinson talks about FY19 results, strategy, pickup in the company's key market, and the company's joint venture with Deakin University for Boron Nitrate Nanotubes.
18 Apr 2024 - Anax Metals (ASX:ANX) CEO Geoff Laing discusses the company's innovative approach to mining as its pioneers bioleaching tech for sustainable resource extraction.
20 Sep 2019 - Prospect Resources Limited (ASX:PSC) Managing Director, Sam Hosack provides an update on the company's Arcadia lithium project in Zimbabwe, including advanced negotiations with a number of African and international banks on funding.
25 Mar 2024 - Immutep Limited (ASX:IMM) CEO and Executive Director Marc Voigt provides an update on the company's pipeline of clinical trials, focusing on results in head and neck cancer, lung cancer and breast cancer.